[{"id":"303935d7-2425-4c10-9c84-b7b29ee4fe99","acronym":"","url":"https://clinicaltrials.gov/study/NCT04805333","created_at":"2024-01-08T17:17:14.042Z","updated_at":"2025-02-25T15:26:46.929Z","phase":"Phase 1","brief_title":"Phase 1 Dose Escalation of ArtemiCoffee","source_id_and_acronym":"NCT04805333","lead_sponsor":"Frederick R. Ueland, M.D.","biomarkers":" CD99 • ABCF2","pipe":"","alterations":" ","tags":["CD99 • ABCF2"],"overall_status":"Completed","enrollment":" Enrollment 13","initiation":"Initiation: 03/26/2021","start_date":" 03/26/2021","primary_txt":" Primary completion: 02/04/2025","primary_completion_date":" 02/04/2025","study_txt":" Completion: 02/04/2025","study_completion_date":" 02/04/2025","last_update_posted":"2025-02-10"},{"id":"66171eb4-84d6-423c-9850-421ced68c0b3","acronym":"","url":"https://clinicaltrials.gov/study/NCT05362539","created_at":"2022-05-05T15:53:50.233Z","updated_at":"2024-07-02T16:36:10.939Z","phase":"","brief_title":"Novel Urine-Based DNA Methylation Biomarkers for Urothelial Bladder Carcinoma Detection in Patients With Hematuria","source_id_and_acronym":"NCT05362539","lead_sponsor":"Mansoura University","biomarkers":" CDH1 • CD99","pipe":"","alterations":" ","tags":["CDH1 • CD99"],"overall_status":"Completed","enrollment":" Enrollment 246","initiation":"Initiation: 02/01/2019","start_date":" 02/01/2019","primary_txt":" Primary completion: 06/01/2021","primary_completion_date":" 06/01/2021","study_txt":" Completion: 04/01/2022","study_completion_date":" 04/01/2022","last_update_posted":"2022-05-05"}]